Statins: potential new indications in inflammatory conditions

Atherosclerosis. Supplements
Matthias Endres

Abstract

Hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are potent cholesterol-lowering drugs. In addition to their cholesterol-lowering properties, statins exert a number of so-called 'pleiotropic', vasculoprotective actions that include improvement of endothelial function, increased nitric oxide (NO) bioavailability, antioxidant properties, stabilisation of atherosclerotic plaques, regulation of progenitor cells, inhibition of inflammatory responses and immunomodulatory actions. Pleiotropic actions of statins may have potential clinical impact in vascular disease beyond cholesterol lowering. The ongoing Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER), for example, tests the effects of statins in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol (LDL-C) and elevated high-sensitivity C-reactive protein (hs-CRP). Additionally, previous studies have shown that although cholesterol is not an established stroke risk factor, statin therapy is associated with a reduction in the incidence of strokes. It is known that sudden withdrawal of statin treatment may acutely impair vascular ...Continue Reading

References

Jul 1, 1990·Annals of Neurology·W C Taylor, W M Landau
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M EndresJ K Liao
Sep 6, 2001·Stroke; a Journal of Cerebral Circulation·N Jonsson, K Asplund
Jun 30, 2001·The New England Journal of Medicine·P M RidkerUNKNOWN Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators
Mar 27, 2002·Circulation·Christopher HeeschenUNKNOWN Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators
Feb 8, 2003·Stroke; a Journal of Cerebral Circulation·Karen GertzMatthias Endres
Mar 12, 2003·The Journal of Experimental Medicine·Orhan AktasFrauke Zipp
Jul 17, 2003·Journal of Neurology·Armando SenaM Graça Morais
Oct 31, 2003·Cerebrovascular Diseases·Peirre AmarencoUNKNOWN SPARCL Investigators
Apr 10, 2004·Stroke; a Journal of Cerebral Circulation·Joan Martí-FàbregasJosep-Lluis Martí-Vilalta
Jun 3, 2004·Circulation·James T Willerson, Paul M Ridker
Jun 17, 2004·Circulation·Jean Davignon
Sep 18, 2004·Stroke; a Journal of Cerebral Circulation·Matthias Endres, Ulrich Laufs
Oct 27, 2004·Archives of Internal Medicine·Frederick A SpencerUNKNOWN National Registry of Myocardial Infarction
Jan 7, 2005·The New England Journal of Medicine·Michael R EhrensteinClaudia Mauri
Apr 2, 2005·Nature Reviews. Neuroscience·Til MengeOlaf Stüve
Apr 7, 2005·Nature Medicine·Hedwich F Kuipers, Peter J van den Elsen

❮ Previous
Next ❯

Citations

Jun 12, 2013·European Journal of Clinical Pharmacology·Xiao-Dan WuYan-Qing Chen
Apr 9, 2008·Journal of Inherited Metabolic Disease·L MeloniSa Muntoni
Aug 26, 2009·International Urology and Nephrology·Erdal KarakayaMustafa Olguner
Aug 21, 2013·Journal of Cardiovascular Translational Research·Valentina ZaninGiorgio Zauli
Jul 17, 2007·Biochemistry. Biokhimii︠a︡·V I Kulinsky
Sep 29, 2011·BMC Cancer·Yana VinogradovaJulia Hippisley-Cox
Dec 30, 2008·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Dolf SegersJon D Laman
Sep 13, 2008·Journal of Endocrinological Investigation·E SantiniA Solini
Dec 7, 2013·Journal of Periodontology·Peter MeiselThomas Kocher
Jan 7, 2009·Cardiovascular Drugs and Therapy·Carlos V SerranoHugo P Monteiro
Mar 18, 2010·Immunopharmacology and Immunotoxicology·Abbas Mirshafiey, Farhad Jadidi-Niaragh
Sep 19, 2007·Expert Opinion on Emerging Drugs·Paul A Lapchak, Dalia M Araujo
Dec 4, 2012·Expert Opinion on Drug Safety·Henry W C LeungHsiao-Ling Chen
Feb 23, 2008·Annals of Medicine·Sanjay K SinghAlok Agrawal
Jan 15, 2011·The American Journal of the Medical Sciences·Ramin GhazizadehMohammad Ghazizadeh
Jun 1, 2010·Rheumatic Diseases Clinics of North America·Kevin D DeaneV Michael Holers
Jan 16, 2010·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Atsushi Imai, Noriko Suzuki
May 12, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Maria F Lopes-Virella, Gabriel Virella
Jan 20, 2009·Resuscitation·Chia-Chi LeeBang-Gee Hsu
Aug 22, 2008·International Journal of Cardiology·Dimitris TousoulisChristodoulos Stefanadis
Sep 9, 2008·Translational Research : the Journal of Laboratory and Clinical Medicine·Adriano Paula SabinoAna Paula Fernandes
Jun 3, 2008·Atherosclerosis·Gabriel Virella, Maria F Lopes-Virella
Oct 26, 2007·Brain Research Reviews·Akhlaq A FarooquiTahira Farooqui
Mar 14, 2007·Resuscitation·Chung-Hua ChenBang-Gee Hsu
Jul 3, 2009·Journal of Pineal Research·Fedor Simko, Olga Pechanova
Aug 19, 2007·European Journal of Clinical Investigation·F Simko
Oct 31, 2012·The British Journal of Dermatology·C MaA W Armstrong
Jun 16, 2009·Medicinal Research Reviews·Marek Jakobisiak, Jakub Golab
Sep 3, 2008·Immunopharmacology and Immunotoxicology·Abbas Mirshafiey, Monireh Mohsenzadegan
Jan 21, 2014·Reproductive Toxicology·Gabriel Adan Araújo LeiteWilma De Grava Kempinas
Nov 9, 2010·International Journal of Pharmaceutics·Francesca UngaroMaria Immacolata La Rotonda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Matthias Endres
Current Atherosclerosis Reports
Bo Ziedén, Anders G Olsson
Journal of the American College of Cardiology
Rainer Schulz
© 2021 Meta ULC. All rights reserved